[go: up one dir, main page]

DK1067904T3 - Faste, hurtigt disintegrerende cetirizinformuleringer - Google Patents

Faste, hurtigt disintegrerende cetirizinformuleringer

Info

Publication number
DK1067904T3
DK1067904T3 DK99922050T DK99922050T DK1067904T3 DK 1067904 T3 DK1067904 T3 DK 1067904T3 DK 99922050 T DK99922050 T DK 99922050T DK 99922050 T DK99922050 T DK 99922050T DK 1067904 T3 DK1067904 T3 DK 1067904T3
Authority
DK
Denmark
Prior art keywords
fixed
rapidly disintegrating
cetirizine formulations
cetirizine
formulations
Prior art date
Application number
DK99922050T
Other languages
Danish (da)
English (en)
Inventor
Wolfram Tritthart
Mario Andre Piskernig
Original Assignee
Asta Medica Ag
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag, Viatris Gmbh filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK1067904T3 publication Critical patent/DK1067904T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
DK99922050T 1998-03-31 1999-03-20 Faste, hurtigt disintegrerende cetirizinformuleringer DK1067904T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (fr) 1998-03-31 1999-03-20 Formulations solides et a decomposition rapide contenant de la cetirizine

Publications (1)

Publication Number Publication Date
DK1067904T3 true DK1067904T3 (da) 2002-04-02

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99922050T DK1067904T3 (da) 1998-03-31 1999-03-20 Faste, hurtigt disintegrerende cetirizinformuleringer

Country Status (30)

Country Link
US (1) US6245353B1 (fr)
EP (1) EP1067904B1 (fr)
JP (1) JP2002509873A (fr)
KR (1) KR100653568B1 (fr)
CN (1) CN1136838C (fr)
AR (1) AR018828A1 (fr)
AT (1) ATE209899T1 (fr)
AU (1) AU750140B2 (fr)
BG (1) BG64741B1 (fr)
BR (1) BR9909233A (fr)
CA (1) CA2326809C (fr)
CY (1) CY1107331T1 (fr)
CZ (1) CZ300704B6 (fr)
DE (2) DE19814256A1 (fr)
DK (1) DK1067904T3 (fr)
ES (1) ES2168013T3 (fr)
HU (1) HU227477B1 (fr)
IL (1) IL138606A (fr)
NO (1) NO329071B1 (fr)
NZ (1) NZ506988A (fr)
PL (1) PL191266B1 (fr)
PT (1) PT1067904E (fr)
RU (1) RU2216318C2 (fr)
SI (1) SI1067904T1 (fr)
SK (1) SK284476B6 (fr)
TR (1) TR200002809T2 (fr)
TW (1) TWI233808B (fr)
UA (1) UA57615C2 (fr)
WO (1) WO1999049843A1 (fr)
ZA (1) ZA200005134B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03000520A (es) 2000-07-17 2003-10-06 Yamanouchi Pharma Co Ltd Composicion farmaceutica mejorada en absorbabilidad peroral..
NZ534039A (en) * 2002-01-15 2006-08-31 Ucb Farchim S Formulations of pharmaceutical compositions for oral administration
PL372904A1 (en) * 2002-04-04 2005-08-08 Pfizer Products Inc. Palatable chewable tablet
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
CA2629904C (fr) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Systeme d'administration orale de compose therapeutique
ES2564056T3 (es) * 2008-09-05 2016-03-17 Johnson & Johnson Consumer Inc. Método para hacer pastillas de cetirizina
WO2010103384A1 (fr) * 2009-03-13 2010-09-16 Nucitec S.A. De C.V. Compositions et méthodes de traitement et prévention de maladies cardiovasculaires
EP2571484A2 (fr) * 2010-05-18 2013-03-27 Mahmut Bilgic Formulations effervescentes
AU2013274378B2 (en) 2012-06-12 2016-06-02 The Procter & Gamble Company Effervescent dosage form
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
EP3061501A1 (fr) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition pour le traitement de l'acné
EP3117825A1 (fr) 2015-07-16 2017-01-18 Rottapharm S.p.A. Formulation orale comprenant de la berbérine et un extrait de morus alba
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (fr) * 2017-11-15 2019-05-23 Berkeley Nox Limited Nouveaux compléments alimentaires
ES2945809T3 (es) 2019-10-02 2023-07-07 Intas Pharmaceuticals Ltd Composiciones farmacéuticas sólidas efervescentes prácticamente sin sodio
EP4099977A1 (fr) * 2020-02-03 2022-12-14 Johnson & Johnson Consumer Inc. Comprimé à mâcher monocouche comprenant de la cétirizine
CN120437087A (zh) 2024-02-01 2025-08-08 科赴品牌有限责任公司 一种口腔溶解膜制剂、其用途及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
SK279279B6 (sk) * 1991-05-13 1998-09-09 The Boots Company Plc S(-)-nátrium-2-(4-izobutylfenyl)propionát-dihydrát
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
WO1994008551A2 (fr) * 1992-10-09 1994-04-28 The Procter & Gamble Company Procedes et compositions pharmaceutiques destines au traitement des symptomes du rhume
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
ATE140621T1 (de) * 1993-04-15 1996-08-15 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen wirkstoff, und verfahren zur herstellung
JPH08509725A (ja) * 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
NO20004722D0 (no) 2000-09-21
ATE209899T1 (de) 2001-12-15
WO1999049843A1 (fr) 1999-10-07
BG64741B1 (bg) 2006-02-28
TR200002809T2 (tr) 2000-12-21
NO329071B1 (no) 2010-08-16
PL343199A1 (en) 2001-07-30
NZ506988A (en) 2002-05-31
ES2168013T3 (es) 2002-05-16
SK14312000A3 (sk) 2001-07-10
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
TWI233808B (en) 2005-06-11
IL138606A (en) 2005-07-25
PL191266B1 (pl) 2006-04-28
HU227477B1 (en) 2011-07-28
AR018828A1 (es) 2001-12-12
EP1067904B1 (fr) 2001-12-05
US6245353B1 (en) 2001-06-12
CZ20003481A3 (en) 2001-05-16
DE59900501D1 (de) 2002-01-17
CA2326809C (fr) 2008-11-18
KR100653568B1 (ko) 2006-12-05
CA2326809A1 (fr) 1999-10-07
DE19814256A1 (de) 1999-10-07
AU3925399A (en) 1999-10-18
CN1295464A (zh) 2001-05-16
ZA200005134B (en) 2000-12-21
HUP0102676A2 (hu) 2001-11-28
BR9909233A (pt) 2000-11-28
AU750140B2 (en) 2002-07-11
SK284476B6 (sk) 2005-04-01
JP2002509873A (ja) 2002-04-02
CY1107331T1 (el) 2012-12-19
EP1067904A1 (fr) 2001-01-17
CN1136838C (zh) 2004-02-04
SI1067904T1 (en) 2002-04-30
BG104843A (en) 2001-07-31
HK1036217A1 (en) 2001-12-28
IL138606A0 (en) 2001-10-31
HUP0102676A3 (en) 2002-12-28
KR20010034718A (ko) 2001-04-25
CZ300704B6 (cs) 2009-07-22
RU2216318C2 (ru) 2003-11-20
UA57615C2 (uk) 2003-06-16

Similar Documents

Publication Publication Date Title
DK1067904T3 (da) Faste, hurtigt disintegrerende cetirizinformuleringer
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
TR199901077A3 (tr) Ispençiyari formülasyonlar.
NO20004240D0 (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
PT1130966E (pt) Formulacoes antiparasitarias
DK1168916T3 (da) Landbrugskemikalieformuleringer
DZ3212A1 (fr) Contacteur-disjoncteur.
EP1083926A4 (fr) Vaccin
DE69906737D1 (de) Mischvorrichtung
IS6398A (is) Lyfjablöndur
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
IS5694A (is) Bóluefni
DK1149106T3 (da) 4,5-azolo-oxindoler
DE60014639D1 (de) Riechstoffe
DE69908356D1 (de) Riechstoffe
ID26368A (id) Turunan-turunan 2 deoksi higromisin
IS5877A (is) Ný efnablanda
DE69903532D1 (de) 4-isobutylcyclohexanol enthaltende riechstoffe
IT1301684B1 (it) Acilperossidi perfluoropolieterei e procedimento per il loroottenimento.
IS5879A (is) Ný efnablanda
ES1042496Y (es) "pilona sumible".